Acute large vessel occlusion due to underlying intracranial atherosclerotic stenosis (ICAS-LVO) increases the difficulty of revascularization, resulting in frequent re-occlusion. The establishment of its pathogenesis before endovascular treatment (EVT) is beneficial for patients. We aimed at developing and validating a clinical prediction model for ICAS-LVO patients before EVT.
Methods
Patients with acute large vessel occlusion at Jining No. 1 People’s Hospital from January 2019 to September 2021 were retrospectively included as the training cohort. The 70 patients who met the inclusion and exclusion criteria were included in the validation cohort (October 2021 to May 2022). Demographics, onset form, medical history, digital subtraction angiography (DSA) imaging data, and laboratory test data were collected. Preprocedural parameters for the ICAS-LVO risk prediction model were established by stepwise logistic regression controlling for the confounding effects. Then, we constructed a nomogram model and evaluated its performance via the Hosmer-Lemeshow goodness-of-fit test, area under the ROC curve (AUC) analysis.
Results
The 231 acute LVO patients were included in the final analysis, 74 (32.3%) patients were ICAS-LVO. A preoperative diagnosis prediction model consisting of five predictors for ICAS-LVO, including fluctuating symptoms, NIHSS < 16, atrial fibrillation, tapered sign, and ASITN/SIR score ≥ 2. The model depicted an acceptable calibration (Hosmer-Lemeshow test, p = 0.451) and good discrimination (AUC, 0.941; 95% confidence interval, 0.910–0.971). The optimal cut-off value for the ICAS-LVO scale was 2 points, with 86.5% sensitivity, 91.1% specificity, and 90.5% accuracy. In the validation cohort, the discriminative ability was promising with an AUC value of 0.897, implying a good predictive performance.
Conclusion
The established ICAS-LVO scale, which is composed of five predictors: fluctuating symptoms, NIHSS < 16, atrial fibrillation, tapered sign, and ASITN/SIR score ≥ 2, has a good predictive value for ICAS-LVO in Chinese populations.
Introduction
Globally, acute ischemic stroke (AIS) due to large vessel occlusion (LVO) is among the leading causes of mortality and disability. Several randomized controlled trials [1‐5] have shown that mechanical thrombectomy (MT) can effectively and safely improve the 90-day clinical outcomes for patients with anterior circulation acute ischemic stroke caused by LVO. It has been reported that MT is a potential option for treatment of acute vertebrobasilar artery occlusion [6‐8]. Currently, endovascular treatment (EVT) has become the standard treatment for acute ischemic stroke in patients with LVO [9]; however, treatment outcomes of EVT for acute ischemic stroke with LVO are not always ideal. Shorter times to recanalization and higher recanalization rates are important for favorable prognostic outcomes [10].
Large vessel occlusion due to intracranial atherosclerosis (ICAS-LVO) is prevalent among Asians, and the incidences are higher than those found in other areas of the world [11]. Compared to LVO caused by embolism, stent–retriever and aspiration thrombectomy techniques are less efficacious in ICAS-LVO [12], with a markedly low recanalization rate, high re-occlusion rate and longer puncture-to-reperfusion time during endovascular procedures. Successful revascularization requires rescue treatment with intra-arterial thrombolysis, balloon angioplasty, or stenting [13‐15]. Establishment of its pathogenesis before interventional surgery will inform on targeted treatment and help to have a smooth procedure.
Anzeige
Unique pathogenesis is associated with more complex and time-consuming surgical procedures, which present significant challenges in ICAS-LVO intervention [16, 17]. Therefore, a new, accurate and comprehensive predictive modality is required for patients with AIS due to ICAS-LVO. In this study, we developed and validated a clinical prediction model for EVT patients.
Methods
Patient Selection
We retrospectively evaluated patients who had been subjected to emergency EVT due to acute large vessel ischemic stroke at Jining No. 1 People’s Hospital stroke center from January 2019 to September 2021. The EVT procedures included stent retrieval, aspiration, angioplasty, stenting or a combination of these techniques.
ICAS-LVO was defined as: (1) intracranial artery fixed stenosis of > 70% when successful reperfusion was achieved and (2) degree of intracranial artery stenosis > 50% in addition to either flow and perfusion impairment on angiography or evident re-occlusion tendency even after adequate treatment with stent retrievers. Embolic-LVO was defined as the absence of residual stenosis in occluded segments after successful reperfusion of the occlusion vessel. The exclusion criteria were: (1) the pathogenesis of occluded vessels due to failed recanalization cannot be reliably assessed, (2) when the cause of vascular occlusion was vasculitis, or moyamoya disease, (3) presence of tandem lesions associated with the carotid or vertebral arteries in the extracranial segment (including extracranial stenosis of the vertebral or carotid artery, carotid dissection) and (4) DSA image information is missing. This retrospective, observational study was approved by the Ethical Committee of No. 1 People’s Hospital of Jining.
Data Collection
Immediately after admission, all patients were subjected to routine blood tests, serum biochemistry tests, blood coagulation tests, electrocardiogram, brain CT NIHSS, mRS, and GCS. Data on demographics, onset form, medical history, digital subtraction angiography (DSA) imaging and laboratory tests were retrospectively collected. Then, data were double entered using the EpiData Entry software v3.1 (EpiData Association, Odense, Denmark). To eliminate selection bias, radiologic assessments were conducted by two neuroradiologists and one neurologist.
Anzeige
Predictive Factors
Fluctuating symptoms are defined as symptomatic fluctuations and progressive aggravation during the early course of neurologic deficits [18]. The tapered sign denotes occlusive clot signs, described as the appearance of a tapered beak-like or flame-like sign [19, 20]. The American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) developed the collateral flow grading scale for DSA [21] to evaluate collateral circulation. The National Institute of Health stroke scale (NIHSS) is a comprehensive stroke scale for evaluating neurological deficits.
Statistical Analyses
Multiple sixfold imputation was performed using the chained equations method to fill the missing blood test results (missing values < 5%). Baseline characteristics were compared between the ICAS-LVO and embolic LVO groups. Categorical variables are presented as numbers and percentages N (%) and compared using the χ2-testand Fisherʼs, exact test. Continuous variables are presented as mean ± standard deviation if normally distributed and as medians and interquartile ranges (IQR), if not normally distributed. The Mann-Whitney U test and the t‑test were used to compare continuous variables between groups.
Multivariable logistic regression analysis was performed for variables with p < 0.05 in the univariate regression analysis. Cut-off values were determined using the maximum of Youden index. Continuous variables were translated into categorical variables. Collinearity diagnosis was performed using the variance inflation factor (VIF). Binary logistic regression (forward, backward) was used to evaluate the predictors and to generate the regression model as well as its related odds ratio (OR), 95% confidence interval (CI), beta coefficient and p values. The beta coefficients were rounded to the closest integer to generate a brief ICAS-LVO scale. The ROC curve was used to calculate the optimal cut-off value of the area under the curve (AUC) to assess the predictive accuracy of the scale and discriminatory ability of the model. The Hosmer-Lemeshow test was performed to assess calibration. A nomogram was built on the brief predictive model as a graphical presentation.
Predictive Models
Analyses were performed using the SPSS software package, version 22 (IBM, Armonk, NY, USA) and R software, version 4.1.3 (R Statistical Software, R Foundation for Statistical Computing, Vienna, Austria).
Fig. 1
Experimental flow chart. LVO Large vessel occlusion, EVT endovascular treatment, DSA digital subtraction angiography, ICAS Intracranial atherosclerosis
SD standard deviation, SBP systolic blood pressure, IQR interquartile range, DBP diastolic blood pressure, CHD coronary heart disease, AF atrial fibrillation, VHD heart valve disease, ICAS intracranial artery stenosis, ICH intracerebral hemorrhage, NIHSS National Institutes of Health stroke scale, GCS Glasgow Coma Scale, MRS modified Rankin scale, ASPECTS Acute Stroke Programme Early Computed Tomography Score, pc-ASPECTS posterior circulation Acute Stroke Programme Early Computed Tomography Score, ASITN/SIR score ASITN/SIR American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology
Table 2
Laboratory findings of the modelling group
Variables
ICAS-LVO
Group (n = 74)
Embolic-LVO
Group (n = 157)
p-value
WBC (109 × /L) median [IQR]
11.19 [8.29, 13.57]
9.53 [7.02, 12.51]
0.035
Hb (g/L) median [IQR]
139.00 [126.75, 148.00]
132.00 [119.00, 147.68]
0.106
Platelets (109 × /L) mean ± (SD)
245.67 ± 60.60
207.72 ± 64.56
0.540
HbA1 mean ± (SD)
6.89 ± 1.74
6.34 ± 1.68
0.510
Neutrophils (×109/L) median [IQR]
9.80 [6.45, 11.1]
7.49 [5.56, 11.40]
0.040
Lymphocytes (×109/L) median [IQR]
1.07 [0.80, 1.58]
1.26 [0.81, 1.93]
0.194
NLR median [IQR]
8.47 [5.07, 11.83]
6.40 [3.80, 10.96]
0.037
VLDL (mmol/L) median [IQR]
0.71 [0.43, 1.10]
0.52 [0.31, 0.73]
0.002
LDL (mmol/L) mean ± (SD)
2.79 ± 1.14
2.33 ± 0.85
0.010
TC (mmol/L) mean ± (SD)
4.72 ± 1.20
4.07 ± 1.08
0.090
TG (mmol/L) median [IQR]
1.60 [1.03, 2.41]
1.12 [0.73, 1.63]
0.001
HDL (mmol/L) median [IQR]
1.03 [0.90, 1.38]
1.09 [0.95, 1.31]
0.896
Apo A (nmol/L) median [IQR]
27.85 [13.20, 68.60]
25.90 [11.20, 67.37]
0.379
SOD (U/mL) median [IQR]
138.50 [124.00, 157.00]
137.00 [120.00, 152.00]
0.581
Fibrinogen (g/L) median [IQR]
2.60 [2.06, 3.43]
2.53 [2.08, 3.12]
0.316
INR median [IQR]
1.01 [0.94, 1.08]
1.07 [1.01, 1.15]
0.012
APTT(s) median [IQR]
25.05 [23.00, 29.38]
26.10 [23.00, 31.50]
0.451
PT median [IQR]
11.55 [10.90, 12.40]
12.40 [11.25, 14.20]
< 0.001
TT (s) median [IQR]
18.30 [16.38, 21.23]
17.60 [16.10, 22.40]
0.499
Procalcitonin median [IQR]
0.05 [0.05, 0.12]
0.05 [0.05, 0.11]
0.337
WBC white blood cells, Hb hemoglobin, HbA1c glycated hemoglobin, NLR NLR neutrophil-to-lymphocyte ratio, VLDL very low-density lipoproteins, LDL low-density lipoproteins, HDL high-density lipoproteins, TG triglyceride, TC total cholesterol, Apo A lipoprotein A, SOD superoxide dismutase, PT prothrombin time, TT thrombin time, APTT activated partial thromboplastin time, INR international normalized ratio
Table 3
Predictive factors for ICAS-LVO
Variable
β‑coefficient
Standard error
Wald
OR (95%CI)
p-value
Fluctuating symptoms
3.071
0.599
26.245
21.56 (6.66, 69.8)
< 0.001
NIHSS < 16
1.287
0.479
7.220
3.62 (1.42, 9.3)
0.007
AF
−3.312
0.717
21.321
0.04 (0.01, 0.1)
< 0.001
ASITN/SIR score
2.362
0.504
22.005
10.61 (3.96, 28.5)
< 0.001
Tapered sign
1.491
0.677
4.850
4.44 (1.18, 16.8)
0.028
NIHSS National Institute of Health stroke scale, AF atrial fibrillation, ASITN/SIR score ASITN/SIR American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, β‑coefficient the regression coefficient, OR odds ratio, CI confidence interval
Table 4
Baseline characteristics of the validation group
Variables
ICAS-LVO
group (n = 19)
Embolic-LVO
group (n = 51)
p-value
Age, (year, mean (SD))
62.68 ± 8.62
63.24 ± 12.55
0.861
Male, (n (%))
9 (47.37%)
35 (68.63%)
0.102
SBP, (mm Hg, median [IQR])
151.11 ± 23.54
146.76 ± 25.72
0.523
DBP, (mm Hg, median [IQR])
93.50 [80.00, 93.00]
86.58 [80.00, 98.00]
0.592
Medical history
Hypertension, (n (%))
13 (68.42%)
23 (45.10%)
0.083
Diabetes, (n (%))
4 (21.05%)
10 (19.6%)
0.980
CHD, (n (%))
3 (15.79%)
11 (21.57%)
0.840
AF, (n (%))
1 (5.26%)
26 (50.98%)
< 0.001
VHD, (n (%))
0 (0.00%)
4 (7.84%)
0.498
ICAS, (n (%))
1 (5.26%)
1 (1.96%)
0.472
Ischemic stroke, (n (%))
3 (15.79%)
6 (11.76%)
0.963
ICH, (n (%))
0 (0.00%)
2 (3.92%)
0.528
Smoking, (n (%))
8 (42.10%)
13 (25.49%)
0.177
Drinking, (n (%))
4 (21.05%)
13 (25.49%)
0.943
Onset form
Fluctuating symptoms, (n (%))
46 (62.20%)
9 (5.7%)
< 0.001
Scores after admission
NIHSS score < 16, (n (%))
13 (68.42%)
15 (29.41%)
0.003
GCS score, (median [IQR])
10 [8.00, 12.00]
9 [6.00, 11.00]
0.120
MRS score, (median [IQR])
4 [4.00, 5.00]
5 [4.00, 5.00]
0.423
ASITN/SIR score ≥ 2, (n (%))
14 (73.68%)
13 (25.49)
0.010
Occlusive clot signs
Tapered sign
16 (25.70%)
5 (9.80%)
0.020
SD standard deviation, SBP systolic blood pressure, IQR interquartile range, DBP diastolic blood pressure, CHD coronary heart disease, AF atrial fibrillation, VHD heart valve disease, ICAS intracranial artery stenosis, ICH intracerebral hemorrhage, NIHSS National Institute of Health stroke scale, GCS Glasgow Coma Scale, MRS modified Rankin Scale, ASITN/SIR score ASITN/SIR American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology
Fig. 2
Schematic presentation of the ICAS-LVO prediction model. NIHSS National Institutes of Health stroke scale, AF atrial fibrillation, ASITN/SIR score American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, β‑coefficient the regression coefficient, OR odds ratios, CI confidence interval
Fig. 3
The ROC curves of the ICAS-LVO predictive scale. a The ROC curves for modelling group, AUC: 0.941, 95% CI 0.910–0.971, p < 0.01; b The ROC curves for validation group, AUC: 0.897, 95% CI 0.819–0.976, p < 0.01. AUC area under curve, CI confidence interval
Fig. 4
Nomogram for predicting the probability of ICAS-LVO in patients with acute ischemic stroke. NIHSS National Institutes of Health stroke scale, AF atrial fibrillation, ASITN/SIR score American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology, ICAS-LVO acute large vessel occlusion due to intracranial atherosclerosis
×
×
×
Patient Baseline Characteristics
From January 2019 to September 2021, a total of 311 consecutive AIS patients with LVO were enrolled in the modelling group. Of the patients 32 were excluded because the pathogenesis of occluded vessels could not be reliably assessed due to unsuccessful revascularization, while 3 were excluded because of missing DSA image information. Then, 272 patients were subjected to DSA analyses. Based on vascular occlusive mechanisms, 45 patients (moyamaya disease n = 2, tandem lesions associated with the carotid or vertebral arteries in the extracranial segment n = 42, including extracranial stenosis of the vertebral or carotid artery carotid dissection n = 35, extracranial carotid dissection n = 7) were excluded. Finally, 231 patients were analyzed (Fig. 1).
Baseline characteristics for the training cohort are presented in Table 1. The median age for all participants was 65 ± 11.54 years and the number of males was 163 (70.56%); baseline NIHSS 18.0 (IQR 15.0, 21.0); GCS score 9.0 (IQR 7, 12); mRS score on admission 5.0 (IQR 4.0, 5.0); ASPECTS (pr-ASPECTS) 7 (IQR 7.0, 8.0); ASITN/SIR score 1.0 (IQR 0.0, 2.0). Risk factors included history of hypertension (n = 122, 52.81%); diabetes (n = 65, 28.14%); CHD n = 67 (29.00%); AF n = 87 (37.66%); VHD n = 19 (8.25%); ICAS n = 14 (6.06%); ischemic stroke n = 50 (21.65%); ICH, n = 6 (2.60%); smoking n = 72 (31.17%); and drinking 72 (n = 31.17%). Based on findings from DSA, patients were divided into two groups: ICAS-LVO group 74 (32.04%) and embolic-LVO group 157 (67.96%).
The ICAS-LVO and embolic-LVO groups differed in various aspects (Tables 1 and 2). Compared to the embolic-LVO group, patients with ICAS-LVO were younger, male, had higher blood pressure and blood lipid levels at admission (SBP:157.53 mmHg ± 23.78 mmHg vs. 149.41 mmHg ± 23.44 mmHg, p = 0.016, DBP: 93.50 mmHg [IQR 80.00 mmHg, 102.00 mmHg] vs. 85.00 mmHg [IQR 75.00 mmHg, 95.00 mmHg] p = 0.001; VLDL, very-low-density lipoprotein (0.71 mmol/L [IQR 0.43 mmol/L, 1.10 mmol/L] vs. 0.52 mmol/L [IQR 0.31 mmol/L, 0.73 mmol/L], p = 0.002; LDL, low density lipoproteins (2.79 mmol/L ± 1.14 mmol/L vs. 2.33 mmol/L ± 0.85 mmol/L, p = 0.010); TG, triglyceride (1.60 mmol/L [IQR 1.03 mmol/L, 2.41 mmol/L] vs. 1.12 mmol/L [IQR 0.73 mmol/L, 1.63 mmol/L]), p = 0.001) current smoking and drinking (40.50% vs. 26.90%), p = 0.037; 40.50% vs. 26.90%, p = 0.035), and had lower baseline NIHSS scores 15[IQR 12.00, 20.00] vs. 19[IQR 16.00, 21.50] p = 0.001; better collateral circulation ASITN/SIR score 2.00[IQR 1.00, 3.00] vs. 1.00[IQR 0.00, 1.00], p < 0.001. The embolic-LVO group had more cases of atrial fibrillation (52.90% vs. 5.40%, p < 0.001) and heart valve disease (11.5% vs. 1.40%, p = 0.09); INR (1.07[IQR 1.01, 1.15] vs. 1.01 [IQR 0.94, 1.08] p < 0.001); PT, (12.40 [IQR 11.25, 14.20] vs. 11.55 [IQR 10.90, 12.40], p = 0.001); WBC, (9.53×109/L [IQR 7.02×109/L, 12.51×109/L] vs. 11.19×109/L [IQR 8.29×109/L, 13.57×109/L], p = 0.035); neutrophils, (7.49×109/L [IQR 5.56×109/L, 11.40×109/L] vs. 9.80×109/L[IQR 6.45×109/L, 11.1×109/L], p = 0.040); NLR (6.40 [IQR 3.80, 10.96] vs. 8.47 [IQR 5.07, 11.83], p = 0.037) and a lower proportion of ICAS history (3.80% vs. 10.80%, p = 0.003) when compared to the ICAS-LVO group.
The internal carotid artery siphon, and the trunks before bifurcation in the M1 segment of the middle cerebral artery (MCA), mid-lower segment of the basilar artery are the most common intracranial sites of stenosis [22]. In this study, there was a predominance of anterior circulation LVO (163, 70.6%) and ICAS (42, 25.74%). Of the 68 (29.4%) posterior circulation stroke patients, 32 (47.06%) had intracranial stenosis. Specific sites for stenosis among the 74 ICAS patients were: M1 segments of the MCA (34, 45.95%), communicating segment of the internal carotid artery (3, 4.04%), ophthalmic segment of internal carotid artery (5, 6.76%), middle and lower segments of basilar artery (19, 25.68%) and V4 segment of the vertebral artery (13, 17.57%).
Anzeige
After excluding factors with collinearity or clinical relations with others, there were five more variables in the prediction model: fluctuating symptoms, NIHSS < 16 (cut-off value, 16), AF, tapered, ASITN/SIR score ≥ 2 (cut-off value, 2). The model depicted acceptable calibration (Hosmer-Lemeshow test, p = 0.451) and good discrimination (AUC, 0.941; 95% CI, 0.910–0.971). The β‑coefficients of the five predictors are shown in Table 3. The optimal cut-off value for the ICAS-LVO scale was 2 points with 86.5% sensitivity, 91.1% specificity, and 90.5% accuracy (Fig. 2). ICAS-LVO scale was developed as a nomogram (Fig. 4).
Validation Group
A total of 70 patients were included in the final analysis, ICAS-LVO (19, 27.14%) the discrimination ability was still promising with an AUC value of 0.897 and a good predictive performance (Fig. 3; Table 4).
Discussion
Early and accurate diagnosis of ICAS-LVO before interventional surgery is particularly important to help select the most appropriate device [23]. It is well known that preoperative etiology is relatively difficult to predict. In particular, vascular occlusion of intracranial segments. Tandem occlusion due to atherosclerotic stenosis of extracranial arteries or a carotid dissection is easily recognized early based on anatomical structures and unique imaging [24‐26]. Currently, some predictors have been shown to distinguish between ICAS-LVO and embolism LVO with acute ischemic stroke patients. The high-resolution vessel wall magnetic resonance imaging (MRI) has limited applications in assessment of LVO type due to delays in treatment [27‐29]. Some of the predictive studies were based on intraprocedural angiographic signs (IPASs) [19]. Although microcatheter “first-pass effects” exhibit reliable outcomes in identification of ICAS, they need a microcatheter through the area of total occlusion, which seems lacking in predicting models [30].
Tapered sign is defined as the appearance of a tapered beak-like or flame-like sign on DSA imaging [31‐33]. Tapered signs are vital for identifying ICAS before an operation, but also present in occlusions due to arterial dissection [34]. Tapered signs in the petrocavernous segment of ICA or the origin of basilar artery are poorly predictive of ICAS-LVO [20]. ICAS-LVO patients exhibit a unique clinical history, including frequently present progressive or fluctuating symptoms [18], better collateral circulation [23], hypertension, diabetes, smoking [22], lower admission NIHSS score [35] and are younger than embolic-LVO group. A pre-EVT in situ atherosclerotic thrombosis (ISAT) predictive model formulated by Xing Jin et al. consists of three predictive factors: history of hypertension, atrial fibrillation rhythm, and dichotomous serum glucose levels. The ISAT scale is only applicable to patients with acute vertebrobasilar arterial occlusion [36]. Compared with previous studies, our study focused on the preoperative judgment of ICAS-LVO. The higher predictive value of the model helps in the accurate identification of ICAS in intracranial occluded segments, ease to implement and promotion.
Anzeige
Collateral circulation plays an important role in preserving perfusion and stabilizing cerebral blood flow in acute occlusion [37]. Chronic atherosclerotic intracranial arterial stenosis may lead to a compensatory adjustment in the brain. Collateral circulation has been shown to be better in patients with ICAS-LVO than in those without chronic stenosis, implying that good collateral circulation is a predictor of ICAS-LVO [37‐39]. There is a significant association between angiographic collateral scores and baseline NIHSS scores [40].
We included variables that were associated with ICAS-LVO as predictors into the analysis. Binary logistic stepwise regression analysis was performed to evaluate the predictors and generate the ICAS-LVO scale, which had 5 predictors; fluctuating symptoms, NIHSS < 16, AF, tapered sign, and ASITN/SIR score ≥ 2. These 5 predictors are easily available clinically. This scale was shown to have the ability to identify the pathogenesis of intracranial vascular occlusion before interventional therapy and to enhance the identification of acute cerebral infarction due to ICAS-LVO. It is important for neurointerventionalists to perform optimal revascularization strategies to reduce the difficulty of surgery and shorten the vascular recanalization time, although, the preferred initial treatment during interventional therapy for ICAS-LVO patients has yet to be established; however, the identification of ICAS-LVO before EVT may improve recanalization rates with more targeted revascularization techniques and shorten recanalization times with early remedial measures [20, 36, 41]. The primary goal of recanalization is to rapidly open the occluded artery and remove the clot. The structure of intracranial atherosclerosis occlusive lesions is different from cardiogenic emboli [23]. Aspiration catheter recanalization for recanalization of ICAS-LVO exhibited poor outcomes [42, 43]. Stent retrievers as a first-line device may achieve a higher success rate than suction catheters in patients with ICAS-LVO [41]; however, repeated stent retrievers thrombectomy is associated with the possibility of intima injuries around the ICAS, which activates the platelets, easily resulting in occlusion again [44]. To eliminate potential stenosis and prevent re-occlusion, nearly half of ICAS-LVO patients require angioplasty with or without stent implement rescue treatment. Rescue treatment is a complex and time-consuming process that requires individualized treatment strategies [45‐47].
Limitations
There are several limitations in this study. First, as a retrospective observational study conducted in a single center, there may be information bias. Second, the clinical prediction models drawn from this study are limited by the relatively small sample size. Our findings should be verified via further external validation and their generalizability evaluated using large sample, multicenter datasets.
Conclusion
The predictive scale comprising of fluctuating symptoms, NIHSS < 16, atrial fibrillation, tapered sign, and ASITN/SIR score ≥ 2 has a promising predictive value for ICAS-LVO before EVT in ischemic stroke due to acute large-vessel occlusion patients.
Anzeige
Declarations
Conflict of interest
Y. Cai, Y. Gu, Y. Wang, P. Wang, L. Zhang, C. Liu, J. Chu, H. Li, Z. Lu, Y. Zhou and H. Liu declare that they have no competing interests.
Ethical standards
This retrospective, observational study was approved by the Ethics Committee of No. 1 People’s Hospital of Jining. Number:2021 the Ethics Committee of the No.1 People’s Hospital of Jining (107). The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.
Mit e.Med Neurologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes, den Premium-Inhalten der neurologischen Fachzeitschriften, inklusive einer gedruckten Neurologie-Zeitschrift Ihrer Wahl.
Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.
Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Update Radiologie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
